Provided by Tiger Trade Technology Pte. Ltd.

Penumbra

335.10
-1.3200-0.39%
Post-market: 335.100.00000.00%17:20 EDT
Volume:559.64K
Turnover:187.62M
Market Cap:13.12B
PE:74.14
High:337.37
Open:337.37
Low:334.80
Close:336.42
52wk High:362.41
52wk Low:221.26
Shares:39.16M
Float Shares:37.83M
Volume Ratio:0.92
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.52
EPS(LYR):4.52
ROE:13.78%
ROA:7.04%
PB:9.19
PE(LYR):74.14

Loading ...

Nyse Halt Penumbra Inc News Pending Lst $339.225000

THOMSON REUTERS
·
Feb 26

U.S. Earnings Preview: After Market Close Feb. 24

Dow Jones
·
Feb 25

Analysts Offer Insights on Healthcare Companies: Penumbra (PEN), Orchestra BioMed Holdings (OBIO) and Teladoc (TDOC)

TIPRANKS
·
Feb 21

Penumbra’s Indigo Post‑Market Study in Japan Reaches Completion, Setting the Stage for New Real‑World Data

TIPRANKS
·
Feb 05

Boston Scientific Corp Outlook Q1 2026 Adjusted EPS of $0.78 to $0.80

THOMSON REUTERS
·
Feb 04

Boston Scientific Corp: Net Sales Growth for Q1 of 2026 to Be Approx 10.5 to 12.0 Percent on a Reported Basis

THOMSON REUTERS
·
Feb 04

Is Peninsula Energy (ASX:PEN) Quietly Reframing Its Uranium Ambitions Through Mine Unit 4’s Outperformance?

Simply Wall St.
·
Jan 31

BTIG Remains a Hold on Penumbra (PEN)

TIPRANKS
·
Jan 27

Boston Scientific Builds Neurovascular Scale With US$14.5b Penumbra Deal

Simply Wall St.
·
Jan 27

Peninsula Energy (ASX:PEN) Valuation Check As Lance Reset Progresses Ahead Of Schedule

Simply Wall St.
·
Jan 26

Assessing Penumbra (PEN) Valuation After Strong Recent Share Price Momentum

Simply Wall St.
·
Jan 25

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

Dow Jones
·
Jan 24

Is Peninsula Energy’s (ASX:PEN) Lance Acidification Reset Quietly Redefining Its Long-Term Uranium Strategy?

Simply Wall St.
·
Jan 23

Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface

Benzinga_recent_news
·
Jan 22

RBC Downgrades Penumbra to Sector Perform From Outperform, Raises Price Target to $374 From $355

MT Newswires Live
·
Jan 20

Penumbra Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
Jan 20

Penumbra downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Jan 20

Penumbra downgraded to Hold from Buy at Canaccord

TIPRANKS
·
Jan 20

Penumbra: Rating Cut to Hold as Boston Scientific Takeout Caps Upside at $374 Deal Price

TIPRANKS
·
Jan 20

Boston Scientific: Undervalued Ahead of Strong Q4 Results, 2026 Outlook, and PEN Acquisition Catalyst

TIPRANKS
·
Jan 17